ArticleNPJ precision oncology2025
Predicting immune responsiveness in ER-positive breast cancer for personalized therapy: a population-based study.
Axel Stenmark Tullberg et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it